Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Long Term Debt 2020–2025
Eli Lilly and Company annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Eli Lilly and Company long term debt as of December 31, 2025: 40.87B, a 43.26% increase year-over-year.
- Eli Lilly and Company long term debt for 2025 were 40.87B, a 43.26% increase from 2024.
- Eli Lilly and Company long term debt for 2024 were 28.53B, a 55.71% increase from 2023.
- Eli Lilly and Company long term debt for 2023 were 18.32B, a 24.31% increase from 2022.
- Eli Lilly and Company long term debt for 2022 were 14.74B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eli Lilly and Company Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $40,868 |
| 2024 | $28,527 |
| 2023 | $18,321 |
| 2022 | $14,738 |
| 2021 | $15,346 |
| 2020 | $16,587 |
Eli Lilly and Company Long Term Debt — FAQ
Eli Lilly and Company (LLY) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's long term debt history?
The chart and table above show Eli Lilly and Company's long term debt by year and by quarter, including the growth rate.